These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29210637)

  • 41. DNA interaction, antimicrobial, anticancer activities and molecular docking study of some new VO(II), Cr(III), Mn(II) and Ni(II) mononuclear chelates encompassing quaridentate imine ligand.
    Abdel-Rahman LH; Abu-Dief AM; Aboelez MO; Hassan Abdel-Mawgoud AA
    J Photochem Photobiol B; 2017 May; 170():271-285. PubMed ID: 28456118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mono- and binuclear copper(II) complexes of new hydrazone ligands derived from 4,6-diacetylresorcinol: Synthesis, spectral studies and antimicrobial activity.
    Shebl M; El-ghamry MA; Khalil SM; Kishk MA
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 May; 126():232-41. PubMed ID: 24607473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enzyme inhibition as a key target for the development of novel metal-based anti-cancer therapeutics.
    Griffith D; Parker JP; Marmion CJ
    Anticancer Agents Med Chem; 2010 Jun; 10(5):354-70. PubMed ID: 20380633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimicrobial and antitumor activity of platinum and palladium complexes of novel spherical aramides nanoparticles containing flexibilizing linkages: structure-property relationship.
    Elhusseiny AF; Hassan HH
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Feb; 103():232-45. PubMed ID: 23261618
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spectroscopic and biological approach of Ni(II), Cu(II) and Co(II) complexes of 4-methoxy/ethoxybenzaldehyde thiosemicarbazone glyoxime.
    Babahan I; Eyduran F; Coban EP; Orhan N; Kazar D; Biyik H
    Spectrochim Acta A Mol Biomol Spectrosc; 2014; 121():205-15. PubMed ID: 24239764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity.
    Leon IE; Cadavid-Vargas JF; Di Virgilio AL; Etcheverry SB
    Curr Med Chem; 2017; 24(2):112-148. PubMed ID: 27554807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.
    Pellei M; Papini G; Trasatti A; Giorgetti M; Tonelli D; Minicucci M; Marzano C; Gandin V; Aquilanti G; Dolmella A; Santini C
    Dalton Trans; 2011 Oct; 40(38):9877-88. PubMed ID: 21709917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antimicrobial and Structural Properties of Metal Ions Complexes with Thiosemicarbazide Motif and Related Heterocyclic Compounds.
    Namiecińska E; Sobiesiak M; Małecka M; Guga P; Rozalska B; Budzisz E
    Curr Med Chem; 2019; 26(4):664-693. PubMed ID: 29493443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Addressing the gaps in homeostatic mechanisms of copper and copper dithiocarbamate complexes in cancer therapy: a shift from classical platinum-drug mechanisms.
    Njenga LW; Mbugua SN; Odhiambo RA; Onani MO
    Dalton Trans; 2023 May; 52(18):5823-5847. PubMed ID: 37021641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progresses in TCM metal-based antitumour agents.
    Chen ZF; Liang H
    Anticancer Agents Med Chem; 2010 Jun; 10(5):412-23. PubMed ID: 20545619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens?
    Kenny RG; Marmion CJ
    Chem Rev; 2019 Jan; 119(2):1058-1137. PubMed ID: 30640441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
    Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W
    Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure-activity relationships of anticancer ruthenium(II) complexes with substituted hydroxyquinolines.
    Havrylyuk D; Howerton BS; Nease L; Parkin S; Heidary DK; Glazer EC
    Eur J Med Chem; 2018 Aug; 156():790-799. PubMed ID: 30055464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ruthenium compounds as potential therapeutic agents for type 2 diabetes mellitus.
    Maikoo S; Makayane D; Booysen IN; Ngubane P; Khathi A
    Eur J Med Chem; 2021 Mar; 213():113064. PubMed ID: 33279292
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent Research Trends on Bismuth Compounds in Cancer Chemoand Radiotherapy.
    Kowalik M; Masternak J; Barszcz B
    Curr Med Chem; 2019; 26(4):729-759. PubMed ID: 28971764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphoroorganic Metal Complexes in Therapeutics.
    Demkowicz S; Kozak W; Daśko M; Rachon J
    Mini Rev Med Chem; 2016; 16(17):1359-1373. PubMed ID: 27145849
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An Evaluation of the Antioxidant and Anticancer Properties of Complex Compounds of Copper (II), Platinum (II), Palladium (II) and Ruthenium (III) for Use in Cancer Therapy.
    Katarzyna M; Anna S; Zielinska-Blizniewska H; Ireneusz M
    Mini Rev Med Chem; 2018; 18(16):1373-1381. PubMed ID: 29692246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis, characterization, equilibrium study and biological activity of Cu(II), Ni(II) and Co(II) complexes of polydentate Schiff base ligand.
    El-Sherif AA; Shehata MR; Shoukry MM; Barakat MH
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Oct; 96():889-97. PubMed ID: 22935596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel copper complexes as potential proteasome inhibitors for cancer treatment (Review).
    Zhang Z; Wang H; Yan M; Wang H; Zhang C
    Mol Med Rep; 2017 Jan; 15(1):3-11. PubMed ID: 27959411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, spectroscopic studies, molecular modeling and antimicrobial activity of binuclear Co(II) and Cu(II) complexes of 4,6-diacetylresorcinol.
    Shebl M; Khalil SM; Taha A; Mahdi MA
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Sep; 113():356-66. PubMed ID: 23743042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.